Skip to main content
Clinical Trials/NCT05888259
NCT05888259
Enrolling By Invitation
Not Applicable

Changes in Plantar Pressure Distribution After 12 Weeks of Foot Insole Utility in Diabetic Foot Ulcer Patients: a Prospective, Randomized, Double-blinded, Controlled Clinical Trial

Cairo University1 site in 1 country60 target enrollmentStarted: September 17, 2021Last updated:

Overview

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
60
Locations
1
Primary Endpoint
peak pressures

Overview

Brief Summary

The goal of this clinical trial is to find out the changes in peak pressure and pressure-time integral after twelve weeks from the initial utility of foot insoles and eight weeks later as a follow-up in diabetic foot ulcers. Participants will be randomly assigned to foot insole, medication, and wound care (study group) or medication and wound care (control group).

Detailed Description

Insole design The foot insole is 5 mm thick under the flat part of the forefoot and the modification is done by changing the position of the metatarsal bar. This was another 5 mm above the flat part of the foot insole. The proximal/distal position of the metatarsal rod and the cavity distal to the rod (large cavity) were defined using the plantar pressure distribution. The position and shape of the distal end of the metatarsal bar were defined by a line in the area where the plantar pressure was 75% of the maximum plantar pressure. This line also defined the void's proximal border. The void's distal border was housed near the area of peak plantar pressures, where pressure was 10% of peak plantar pressure. The void measured 3 mm in depth. After completing the initial design of the metatarsal bars and void, two variations were created by relocating the metatarsal bar proximal and distal by 2-4% of the insole length depending on the position of the foot ulcer. Based on a previous pilot study, this proportion equates to a distance of 5-7 mm on a size 38 orthotic insole. The orthotic insoles were made of medium-density (Ethylene-vinyl acetate) EVA (50° Shore A) and were manufactured on a CNC machine.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
50 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Reynaud's disease
  • peripheral arterial disease
  • foot deformities
  • foot burns.

Outcomes

Primary Outcomes

peak pressures

Time Frame: 12 weeks

peak pressure for hindfoot, midfoot, hallux, medial and lateral forefoot

pressure-time integrals

Time Frame: 12 weeks

pressure time integral for hindfoot, midfoot, hallux, medial, and lateral forefoot

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hany Mohamed Ibrahim Elgohary

associate professor

Cairo University

Study Sites (1)

Loading locations...

Similar Trials